A functionally defined high-density NRF2 interactome reveals new conditional regulators of ARE transactivation
Jonathan Poh1, Amy H Ponsford1, James Boyd1
1Institute of Translational Medicine, University of Liverpool, UK.
Abstract:
NRF2 (NFE2L2) is a cytoprotective transcription factor associated with >60 human diseases, adverse drug reactions and therapeutic resistance. To provide insight into the complex regulation of NRF2 responses, 1962 predicted NRF2-partner interactions were systematically tested to generate an experimentally defined high-density human NRF2 interactome. Verification and conditional stratification of 46 new NRF2 partners was achieved by co-immunoprecipitation and the novel integration of quantitative data from dual luminescence-based co-immunoprecipitation (DULIP) assays and live-cell fluorescence cross-correlation spectroscopy (FCCS). The functional impact of new partners was then assessed in genetically edited loss-of-function (NRF2-/-) and disease-related gain-of-function (NRF2T80K and KEAP1-/-) cell-lines. Of the new partners investigated >77% (17/22) modified NRF2 responses, including partners that only exhibited effects under disease-related conditions. This experimentally defined binary NRF2 interactome provides a new vision of the complex molecular networks that govern the modulation and consequence of NRF2 activity in health and disease.
Insights
This study maps the human NRF2 interactome, identifying new partners that regulate its activity. Over 77% of these new partners modify NRF2 responses, offering insights into disease and drug resistance.
Area of Science:
- Molecular Biology
- Cellular Biology
- Genetics
Background:
- Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor involved in cellular protection.
- NRF2 dysregulation is implicated in over 60 human diseases, drug resistance, and adverse drug reactions.
Purpose of the Study:
- To systematically map the human NRF2 interactome and identify novel NRF2-interacting partners.
- To functionally characterize the impact of newly identified NRF2 partners on NRF2 activity in health and disease contexts.
Main Methods:
- Systematic testing of 1962 predicted NRF2-partner interactions.
- Verification using co-immunoprecipitation, dual luminescence-based co-immunoprecipitation (DULIP), and live-cell fluorescence cross-correlation spectroscopy (FCCS).
- Functional assessment in NRF2 knockout (NRF2-/-) and disease-model (NRF2T80K, KEAP1-/-) cell lines.
Main Results:
- An experimentally defined, high-density human NRF2 interactome was generated.
- 46 new NRF2 partners were identified and verified.
- Over 77% (17/22) of the newly investigated partners significantly modified NRF2 responses, with some effects specific to disease conditions.
Conclusions:
- The study provides a comprehensive NRF2 interactome, revealing complex regulatory networks.
- Newly identified NRF2 partners play crucial roles in modulating NRF2 activity, particularly under disease-related conditions.
- This resource offers new perspectives on NRF2 function in health and disease, impacting therapeutic strategies.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Master Transcription Regulators
